JAAPA CME Post-Test July 2017
Smoking Cessation: Identifying Readiness to Quit and Designing a Plan | Diabetic Ketoacidosis: Heralding Type 1 Diabetes in Children
Member: Free | Nonmember: $25

Smoking Cessation: Identifying Readiness to Quit and Designing a Plan

Angela Olenik, PharmD, BCPS; Cortney M. Mospan, PharmD, BCACP, BCGP

Clinicians must be prepared to identify tobacco use among patients and implement behavioral interventions to help patients quit. By understanding behavioral interventions and pharmacologic options, clinicians can design an optimal quit plan for each patient. This activity reviews foundations of tobacco cessation, pharmacotherapy updates, and the emergence of e-cigarettes as desirable cessation tools for patients.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify key guidelines and public health resources focused on reducing tobacco-related illness.
  • Discuss point-of-care tools to help identify tobacco dependence and assess patient readiness to quit.
  • Describe risks and benefits of commonly prescribed drug therapies used in tobacco cessation plans.

Diabetic Ketoacidosis: Heralding Type 1 Diabetes in Children

Corinne I. Alois, MPAS, PA-C; Denise Rizzolo, PA-C, PhD

Despite advances in diabetes management, diabetic ketoacidosis (DKA) continues to be a leading cause of morbidity and mortality. Up to one-third of children may present with DKA as the original presentation of type 1 diabetes. These children develop clinical manifestations of DKA including hyperglycemia, acidosis, and ketosis. Clinicians must be able to identify those patients at risk, recognize common signs and symptoms, and start prompt management.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe the pathogenesis, risk factors, and common clinical presentations of DKA.
  • Identify diagnostic criteria as well as evidence-based management approaches for patients presenting with DKA.
  • Discuss patterns of morbidity and mortality associated with DKA in patients with type 1 diabetes.

Accreditation Statement


This activity has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards. 

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Angela Olenik is a primary care clinical pharmacy specialist at Kaiser Permanente of the MidAtlantic States in Springfield, Va. Cortney M. Mospan is an assistant professor of pharmacy at Wingate (N.C.) University School of Pharmacy. Corinne I. Alois is an assistant professor-industry professional in the Department of Clinical Health Professions at St. John’s University in Queens, N.Y., and a guest lecturer and adjunct faculty member in the PA program at Pace University–Lenox Hill Hospital in New York, N.Y. Denise Rizzolo is an associate professor in the PA program at Kean University in Union, N.J., and assistant clinical Professor at the Pace Completion Program, New York, N.Y. The authors has disclosed no potential conflicts of interest, financial or otherwise.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Journal-based CME
6648 Registered Users